Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 445 of 5804
-
New drug cocktail aims to tame deadly transplant side effect
Disease control Recruiting nowOptimization of bendamustine-containg graft-versus-host disease (GVHD) prophylaxis to reduce the incidence of secondary haemophagocytic lymphohistiocytosis and GVHD
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New nasal spray COVID-19 booster could replace needles
⭐️ VACCINE ⭐️ Recruiting nowThis Phase I/II trial in France evaluates safety and immunogenicity of a booster dose of an intranasal COVID-19 vaccine (LVT-001) versus a booster dose of a COVID-19 mRNA vaccine (Pfizer-BioNTech) in healthy adult volunteers. As a first-in-human trial, Phase I will assess the sa…
Phase: PHASE1, PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:05 UTC
-
New drug IBI362 takes on semaglutide in fatty liver showdown
Disease control OngoingThis is a multicenter, randomized, open-label Phase 3 clinical study comparing the efficacy and safety of IBI362 9 mg QW versus Semaglutide 2.4 mg QW in overweight or obese (BMI≥27kg/m2) MAFLD subjects. Subjects will be randomly assigned to IBI362 9 mg and Semaglutide 2.4 mg grou…
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pee test could revolutionize HIV treatment adherence
Disease control Recruiting nowAntiretroviral therapy (ART) has significantly decreased the morbidity and mortality of HIV infection. However, adherence challenges in taking daily oral ART persist. A retrospective cohort study across 31 countries from 2010-19 reported that only 65% of people with HIV (PWH) on …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug aims to slow kidney damage in IgA nephropathy
Disease control Recruiting nowIn this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). IgAN is a kidney disease caused by the buildup of an antibody called IgA in the kidneys over time. In people with IgAN, abnormal IgA and other antibod…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New schizophrenia drug aims to ease severe symptoms in hospitalized patients
Symptom relief Recruiting nowThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New vaccine aims to shield toddlers from 24 pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowA Phase 1b clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 42 days)-23 months. The objective of the study is to evaluate the safety and immunogenicity o…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New ultrasound could rival MRI for prostate cancer detection
Diagnosis Recruiting nowThe purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of …
Phase: PHASE3 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New buprenorphine start aims to sidestep fentanyl withdrawal
Disease control Recruiting nowThe goal of this clinical trial is to learn if buprenorphine can be started for opioid use disorder with fentanyl use without requiring or precipitating opioid withdrawal. To be eligible, participants must have moderate or severe opioid use disorder and must have fentanyl detecte…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a quick zapping of bone spots prevent fractures? new trial aims to find out
Disease control OngoingThis phase III trial compares the effect of adding radiation therapy to usual treatment on the occurrence of bone-related complications in cancer patients with high-risk bone metastases that are not causing symptoms, such as pain (asymptomatic). High-risk bone metastases are defi…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for hand function: Non-Invasive therapies tested in spinal cord injury
Disease control Recruiting nowThis study explores two promising therapies for restoring arm and hand function in people with chronic cervical spinal cord injury (SCI), a condition that affects independence and quality of life. It will compare transcutaneous spinal cord stimulation and paired corticospinal-mot…
Phase: PHASE2, PHASE3 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Scan-Guided biopsy could catch hidden prostate cancers
Diagnosis Recruiting nowThe goal is to provide more accurate diagnostic tools and optimized diagnostic workflows for clinically suspected prostate cancer patients with prior negative biopsies, improving early detection rates for csPCa and reducing missed diagnoses.
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Can a simple antibiotic or immunoglobulin shield blood cancer patients from deadly infections?
Disease control Recruiting nowThis study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of d…
Phase: PHASE2, PHASE3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to stall pancreatic cancer after chemo
Disease control Recruiting nowThe main goal of this study is to look at the effectiveness and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib and ipilimumab, on the patients and their pancreatic cancer. This study will involve two different treatment arms. In Arm A, patients will r…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
New trial aims to stop infections in blood cancer patients
Disease control Recruiting nowThis study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers. The best way to find out this information is to directly compare the effect of d…
Phase: PHASE2, PHASE3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New single-dose pill may beat week-long treatment for common STI
⭐️ CURE ⭐️ Recruiting nowThis is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Phase: PHASE4 • Sponsor: Tulane University • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Can immunoglobulin or antibiotics stop infections in blood cancer patients?
Disease control Recruiting nowThis is an adaptive platform study to find out how safe and effective different strategies are in comparison to each other, for preventing infection in patients with blood cancers. It is a comparison between Immunoglobulin and antibiotics use.
Phase: PHASE2, PHASE3 • Sponsor: Monash University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a single infusion of modified immune cells tame autoimmune attacks?
Disease control Recruiting nowThe main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
Phase: PHASE1 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail aims to outdo chemo for tough throat cancer
Disease control Recruiting nowThis is a randomized, open-label, multi-center, phase III study to evaluate the efficacy and safety, and immunogenicity of MRG003 in combination with pucotenlimab in patients with recurrent or metastatic nasopharyngeal carcinoma.
Phase: PHASE3 • Sponsor: Shanghai Miracogen Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug could cut blood transfusions for MDS patients
Disease control Recruiting nowThe main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elritercept works in reducing the need for RBC transfusions over longer periods of time or in adults with high transfusion needs. The s…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC